Barclays’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Sell
19,732
-139,868
-88% -$2.28M ﹤0.01% 3486
2025
Q4
$2.06M Buy
159,600
+16,740
+12% +$177K ﹤0.01% 2917
2025
Q3
$1.21M Sell
142,860
-52,721
-27% -$497K ﹤0.01% 3258
2025
Q2
$1.69M Buy
195,581
+67,673
+53% +$503K ﹤0.01% 2979
2025
Q1
$1.1M Sell
127,908
-50,771
-28% -$361K ﹤0.01% 3047
2024
Q4
$1.2M Buy
178,679
+17,253
+11% +$128K ﹤0.01% 3261
2024
Q3
$1.16M Buy
161,426
+125,311
+347% +$1.15M ﹤0.01% 3261
2024
Q2
$375K Sell
36,115
-53,043
-59% -$530K ﹤0.01% 3219
2024
Q1
$896K Sell
89,158
-72,984
-45% -$785K ﹤0.01% 3207
2023
Q4
$2.47M Buy
162,142
+122,664
+311% +$1.69M ﹤0.01% 2744
2023
Q3
$552K Sell
39,478
-22,999
-37% -$348K ﹤0.01% 2739
2023
Q2
$827K Sell
62,477
-21,828
-26% -$297K ﹤0.01% 2424
2023
Q1
$1.36M Buy
84,305
+18,121
+27% +$320K ﹤0.01% 2508
2022
Q4
$985K Sell
66,184
-82,823
-56% -$1.44M ﹤0.01% 2815
2022
Q3
$2.96M Buy
149,007
+84,922
+133% +$2.1M ﹤0.01% 1485
2022
Q2
$1.31M Buy
64,085
+42,806
+201% +$1.06M ﹤0.01% 2155
2022
Q1
$646K Buy
21,279
+1,330
+7% +$52K ﹤0.01% 2714
2021
Q4
$816K Sell
19,949
-20,284
-50% -$844K ﹤0.01% 2954
2021
Q3
$1.71M Sell
40,233
-65,606
-62% -$3.24M ﹤0.01% 2453
2021
Q2
$5.58M Buy
105,839
+27,206
+35% +$1.35M ﹤0.01% 1528
2021
Q1
$3.49M Buy
78,633
+7,430
+10% +$366K ﹤0.01% 1823
2020
Q4
$3.42M Buy
71,203
+52,288
+276% +$2.52M ﹤0.01% 1807
2020
Q3
$883K Sell
18,915
-322
-2% -$15.8K ﹤0.01% 2798
2020
Q2
$865K Sell
19,237
-182,911
-90% -$7.1M ﹤0.01% 2886
2020
Q1
$5.89M Sell
202,148
-293,772
-59% -$10.9M ﹤0.01% 1337
2019
Q4
$23.6M Buy
495,920
+386,076
+351% +$16.7M 0.01% 864
2019
Q3
$4.16M Sell
109,844
-228,459
-68% -$8.92M ﹤0.01% 2020
2019
Q2
$14.5M Buy
338,303
+176,387
+109% +$8.35M 0.01% 1117
2019
Q1
$8.58M Sell
161,916
-100,605
-38% -$5.78M 0.01% 1319
2018
Q4
$15.5M Sell
262,521
-39,804
-13% -$2.2M 0.01% 897
2018
Q3
$16.5M Buy
302,325
+58,829
+24% +$3.25M 0.01% 962
2018
Q2
$13.1M Buy
243,496
+24,516
+11% +$1.29M 0.01% 1051
2018
Q1
$10.7M Buy
218,980
+188,876
+627% +$8.02M 0.01% 1146
2017
Q4
$1.02M Sell
30,104
-51,286
-63% -$1.8M ﹤0.01% 3093
2017
Q3
$2.76M Buy
81,390
+51,268
+170% +$1.75M ﹤0.01% 2036
2017
Q2
$1.07M Sell
30,122
-35,418
-54% -$1.19M ﹤0.01% 2825
2017
Q1
$1.9M Sell
65,540
-158,084
-71% -$4.4M ﹤0.01% 2148
2016
Q4
$5.38M Sell
223,624
-16,134
-7% -$440K 0.01% 1339
2016
Q3
$7.43M Sell
239,758
-60,730
-20% -$1.92M 0.01% 1039
2016
Q2
$8.79M Buy
300,488
+55,934
+23% +$1.67M 0.01% 909
2016
Q1
$7.46M Sell
244,554
-126,616
-34% -$3.27M 0.01% 921
2015
Q4
$9.84M Buy
371,170
+50,456
+16% +$1.4M 0.01% 894
2015
Q3
$8.66M Buy
320,714
+17,862
+6% +$489K 0.01% 1024
2015
Q2
$8.33M Sell
302,852
-97,716
-24% -$2.37M 0.01% 1144
2015
Q1
$8.41M Sell
400,568
-8,342
-2% -$142K 0.01% 1188
2014
Q4
$7.56M Buy
408,910
+192,112
+89% +$4.11M 0.01% 1378
2014
Q3
$4.66M Buy
216,798
+38,504
+22% +$1.03M ﹤0.01% 1853
2014
Q2
$5.7M Buy
178,294
+83,748
+89% +$2.57M 0.01% 1620
2014
Q1
$2.69M Sell
94,546
-545,908
-85% -$18M ﹤0.01% 2254
2013
Q4
$25M Buy
+640,454
New +$22.2M 0.03% 637
2013
Q3
Sell
-160,028
Closed -$4.95M 7495
2013
Q2
$3.61M Buy
+160,028
New +$3.41M ﹤0.01% 1912

Other funds holding HLF

Barclays's HLF Position: Q1 2026 in Review

Barclays reduced its Herbalife (HLF) stake by 88% in Q1 2026, selling an estimated $2.28M and leaving 19,732 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #3486.

Barclays first reported a position in HLF in Q2 2013 and has held it in 51 quarters since. The position peaked at $25M in Q4 2013. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Barclays held 19,732 shares of Herbalife worth $290K as of Q1 2026.
  • Barclays sold 139,868 Herbalife shares in Q1 2026, an estimated $2.28M.
  • Herbalife made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3486 holding.
  • Barclays first reported a position in Herbalife in Q2 2013 and has held it in 51 quarters since.
  • Barclays's Herbalife position peaked at $25M in Q4 2013.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.